Korean Stock
OWNR
Samik Pharm
★
No Change in Specific Securities Holdings by Officers and Major Shareholders
 05/19/2026, 10:10 AM
PERI
Samik Pharm
★★
Samik Pharmaceutical Q1 2026: Consolidated Revenue KRW 15.5B, Net Profit KRW 1.2B; New Drug Approval and Pipeline Strength
 05/15/2026, 09:06 AM
EXCH
Samik Pharm
★★★★
Samik Pharmaceuticals announces 2026 value-up plan and continued high dividend
 05/06/2026, 11:49 AM